IXICO plc Share Price

Equities

IXI

GB00BFXR4C20

Biotechnology & Medical Research

Market Closed - London S.E. 09:05:04 26/04/2024 pm IST 5-day change 1st Jan Change
8.625 GBX 0.00% Intraday chart for IXICO plc -1.43% -31.00%

Financials

Sales 2024 * 5.2M 6.49M 541M Sales 2025 * - Capitalization 4.17M 5.2M 434M
Net income 2024 * -2M -2.5M -208M Net income 2025 * - EV / Sales 2024 * 0.53 x
Net cash position 2024 * 1.4M 1.75M 146M Net cash position 2025 * - 0 0 EV / Sales 2025 * -
P/E ratio 2024 *
-1.57 x
P/E ratio 2025 *
-
Employees 89
Yield 2024 *
-
Yield 2025 *
-
Free-Float 51.17%
More Fundamentals * Assessed data
Dynamic Chart
1 week-1.43%
Current month+6.48%
1 month-0.29%
3 months-15.85%
6 months-37.27%
Current year-31.00%
More quotes
1 week
8.50
Extreme 8.5
9.00
1 month
8.00
Extreme 8
9.00
Current year
6.35
Extreme 6.35
13.50
1 year
6.35
Extreme 6.35
21.00
3 years
6.35
Extreme 6.35
105.00
5 years
6.35
Extreme 6.35
127.00
10 years
6.35
Extreme 6.35
127.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 63 06/17/06
Director of Finance/CFO 47 31/19/31
Chairman 59 14/13/14
Members of the board TitleAgeSince
Chairman 59 14/13/14
Director/Board Member 48 16/16/16
Director/Board Member 60 05/23/05
More insiders
Date Price Change Volume
26/24/26 8.625 0.00% 0
25/24/25 8.625 -1.43% 6,800
24/24/24 8.75 0.00% 366
23/24/23 8.75 0.00% 4,640
22/24/22 8.75 0.00% 36,748

Delayed Quote London S.E., April 26, 2024 at 09:05 pm IST

More quotes
IXICO plc is a United Kingdom-based company that provides specialist data analytics services to the global biopharmaceutical industry. The services include the collection, analysis, management, and reporting on data generated in the course of a clinical study. The outputs from the data analysis are used to enhance patient selection, monitor drug safety, and assess clinical efficacy of the drug under development. It offers a range of services, such as drug development analytics, imaging operations, post-marketing, and post-marketing. It offers end to end services, including trial design and consultation, project management, imaging site set-up and management, data management, reading and analysis, and regulatory pathway. It offers a range of clinical trial imaging analysis tools, including radiological reads, structural and advanced magnetic resonance imaging (MRI). Its specialist data analytics services identify and measure biomarkers from brain scans and wearable biosensors.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Annual profits - Rate of surprise